RxDoctor Payments Data

Shaun Yockelson, MD

Critical Care Medicine · New Orleans, LANPI 1164798484

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by La Jolla Pharmaceutical Company at 53.6% of the total. Reporting peaked in 2022 at $190 and has fallen 84.4% since, to $30 in 2025. That places this record below the midpoint for critical care medicine clinicians in LA, where the typical reported total is $950.

$355in general payments, 2019–2025

Across 8 payments — averaging $44.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • La Jolla Pharmaceutical Company$190
  • Chiesi USA, Inc.$80
  • Haemonetics Corporation$51
  • Johnson & Johnson$20
  • Medtronic$14
$178,624in research payments, 2019–2025

Across 32 payments — averaging $5582.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Haemonetics Corporation$179K

What the payments were for

  • Food & beverage$355100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$355 in reported general payments places this provider in the 35th percentile of 72 critical care medicine providers in Louisiana.

See all critical care medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$37,209
Medicare patients
119
Services billed
209

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →